[JAMA] VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

zongzongfen Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-08-29 17:34

Reward10points

Louie T, Golan Y, Khanna S, et al. VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial. JAMA. 2023;329(16):1356–1366. doi:10.1001/jama.2023.4314

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

zongzongfen Lv.2

Junior Member

post
reply
points
120

[JAMA] VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial. Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[JAMA] VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.